Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

ClinicalTrials.gov ID: NCT00309244

Public ClinicalTrials.gov record NCT00309244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 1:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere /Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this 13 month study (12 month treatment period and 1 month follow-up period) is to determine whether inhaled insulin is safe and effective in the treatment of type 2 diabetes.

Study identification

NCT ID
NCT00309244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mannkind Corporation
Industry
Enrollment
677 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Oct 16, 2014

2006 – 2008

United States locations

U.S. sites
80
U.S. states
25
U.S. cities
57
Facility City State ZIP Site status
Coastal Clinical Research Inc Mobile Alabama 36608 —
Quality of Life Medical & Research Center Tucson Arizona 85712 —
Southern Arizona VA Healthcare System Tucson Arizona 85723 —
Tucson Clinical Research Tucson Arizona 85741 —
International Clinical Research Network Chula Vista California 91911 —
Saad Hijazi MD Inc Fresno California 93710 —
Valley Research Fresno California 93720 —
Diabetes/Lipid Management and Research Center Huntington Beach California 92648 —
South Bay Clinical Research Inglewood California 90301 —
Southern California Endocrine Center Pasadena California 91105 —
Coastal Biomedical Research Inc Santa Monica California 90404 —
Diabetes Research Center Tustin California 92780 —
University of Miami Diabetes Research Institute Miami Florida 33136 —
International Research Associates LLC Miami Florida 33156 —
Laureate Clinical Research Group Atlanta Georgia 30308 —
Atlanta Pharmaceutical Research Center Dunwoody Georgia 30338 —
North Atlanta Endocrinology & Diabetes PC Lawrenceville Georgia 30045 —
Atlanta Center for Clinical Research Roswell Georgia 30075 —
John H Stoger Jr Hospital of Cook County Chicago Illinois 60612 —
Clintell Inc Skokie Illinois 60076 —
Clintell Inc (Ellyin) Skokie Illinois 60077 —
Medical Research of Louisiana Metairie Louisiana 70002 —
Joslin Diabetes Center University of Maryland Medicine Baltimore Maryland 21201 —
James A Dicke MDPA Towson Maryland 21204 —
Wayne State University Detroit Michigan 48201 —
Michigan Institute of Medicine Livonia Michigan 48152 —
KMED Research Saint Clair Shores Michigan 48081 —
Radiant Research Inc (Minneapolis) Edina Minnesota 55435 —
International Diabetes Center Minneapolis Minnesota 55416 —
Center for Urologic Clinical Trials University of Minnesota Minneapolis Minnesota 55455 —
Amin Radparvar's Private Practice City of Saint Peters Missouri 63376 —
MedEx Healthcare Research Inc St Louis Missouri 63117 —
Billings Clinic Research Division Billings Montana 59101 —
Montana Health Research Institute Billings Montana 59102 —
Creighton Diabetes Center Omaha Nebraska 68131 —
New Mexico Clinical Research & Osteoporosis Center Albuquerque New Mexico 87106 —
University of New Mexico HCS Albuquerque New Mexico 87131 —
Winthrop University Hospital Mineola New York 11501 —
North Shore Diabetes and Endocrine Associates New Hyde Park New York 11042 —
Univeristy of Physicians Group Endocrine Division Staten Island New York 10301 —
Sensenbrenner Primary Care Charlotte North Carolina 28277 —
East Carolina University (Tanenberg) Greenville North Carolina 27834 —
Physician's East PA Greenville North Carolina 27834 —
Valley Medical Primary Care Centerville Ohio 45459 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Providence Health Partners - Center of Clinical Research Dayton Ohio 45439 —
Cleveland Clinic Health System East Cleveland Ohio 44112 —
Wells Institute for Health Awareness Kettering Ohio 45429 —
Oregon Medical Group Clinical Resesarch Eugene Oregon 97401 —
Lane Medical Research Group Eugene Oregon 97404 —
Portland Diabetes & Endocrinology Center Portland Oregon 97210 —
New Hope Research of Oregon Portland Oregon 97219 —
Covance CRU Inc. Portland Oregon 97239 —
Pennsylvania Research Institute Bensalem Pennsylvania 19020 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Upstate Pharmaceutical Research Greenville South Carolina 29615 —
Southeastern Research Associates Inc Taylors South Carolina 29687 —
AM Diabetes and Endocrinology Center Bartlett Tennessee 38133 —
Memphis Internal Medicine PLLC Memphis Tennessee 38119 —
The Endocrine Clinic Memphis Tennessee 38119 —
Israel Hartman MD Arlington Texas 76014 —
South Arlington Primary Care Assoc PA Arlington Texas 76017 —
Dallas Diabetes & Endocrine Center Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Radiant Research Dallas-North Dallas Texas 75231 —
Baylor Endocrine Center Dallas Texas 75246 —
Galenos Research Dallas Texas 75251 —
Spuhler Medical Associates Friendswood Texas 77546 —
Clinical Trial Network Houston Texas 77074 —
Quality Assurance Research Center Inc San Antonio Texas 78205 —
Covenant Clinic Research San Antonio Texas 78229 —
Diabetes & Glandular Disease Research Assoc PA San Antonio Texas 78229 —
SAM Clinical Research Center San Antonio Texas 78229 —
Salt Lake Research Salt Lake City Utah 84107 —
Sentara Medical Group Norfolk Virginia 23502 —
Clinical Research Associates of Tidewater Norfolk Virginia 23507 —
Larry D Stonesifer MD Inc PS Federal Way Washington 98003 —
Rainier Clinical Research Center Inc Renton Washington 98055 —
Cedar Research Tacoma Washington 98405 —
Liberty Research Center Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00309244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2014 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00309244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →